Stock Analysis on Net
Stock Analysis on Net

Eli Lilly & Co. (NYSE:LLY)

$24.99

Common-Size Balance Sheet: Assets

Paying user area

Try for free

Eli Lilly & Co. pages available for free this week:

The data is hidden behind: . Unhide it.

Get access

This is a one-time payment. There is no automatic renewal.

We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Apple Pay Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Eli Lilly & Co., common-size consolidated balance sheet: assets

Microsoft Excel
Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
Cash and cash equivalents
Short-term investments
Accounts receivable, net of allowances
Other receivables
Inventories
Prepaid expenses
Other current assets
Current assets
Investments
Goodwill
Other intangibles, net
Deferred tax assets
Property and equipment, net
Other noncurrent assets
Noncurrent assets
Total assets

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).

Balance sheet item Description The company
Current assets Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. Eli Lilly & Co. current assets as a percentage of total assets decreased from 2021 to 2022 but then increased from 2022 to 2023 exceeding 2021 level.
Property and equipment, net Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. Eli Lilly & Co. property and equipment, net as a percentage of total assets increased from 2021 to 2022 but then slightly decreased from 2022 to 2023.
Noncurrent assets Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer. Eli Lilly & Co. noncurrent assets as a percentage of total assets increased from 2021 to 2022 but then decreased significantly from 2022 to 2023.